TORONTO, ON / ACCESSWIRE / April 25, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the ...
TORONTO, ON / ACCESSWIRE / September 5, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in ...
TORONTO, ON / ACCESSWIRE / December 15, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the ...
Intellipharmaceutics International Inc. IPCI announced the launch of a generic version of schizophrenia drug, Seroquel XR by its marketing and distribution partner in the U.S, Mallinckrodt Public ...
TORONTO, Feb. 6, 2023 /CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, ...
TORONTO, April 14, 2011 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel ...
TORONTO, Feb. 28, 2011 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel ...
Intellipharmaceutics has developed several drug delivery systems based on this technology platform, with a pipeline of products (some of which have received FDA approval) in various stages of ...
Intellipharmaceutics International provided an update on its research and development activities and achievement of a goal in relation to its Rexista abuse-deterrent formulations for opioid and ...
Deal marks the culmination of Vasogen’s search for alternatives after it halted development due to lack of capital. Vasogen and privately held IntelliPharmaCeutics (IPC) inked a merger agreement to ...
Intellipharmaceutics International Inc. IPCI announced the launch of a generic version of schizophrenia drug, Seroquel XR by its marketing and distribution partner in the U.S, Mallinckrodt Public ...
Intellipharmaceutics has developed several drug delivery systems based on this technology platform, with a pipeline of products (some of which have received FDA approval) in various stages of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results